Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.

Radiation therapy has been long utilized as localized cancer treatment. Recent studies have also demonstrated that it has a distant effect by the enhanced immunity, but it rarely occurs. The purpose of this study was to investigate whether X-ray irradiation combined with anti-PD-L1 and anti-CTLA-4 a...

Full description

Bibliographic Details
Main Authors: Yutaka Takahashi, Tomohiro Yasui, Keisuke Tamari, Kazumasa Minami, Keisuke Otani, Fumiaki Isohashi, Yuji Seo, Ryosuke Kambe, Masahiko Koizumi, Kazuhiko Ogawa
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5734786?pdf=render
_version_ 1818952469870280704
author Yutaka Takahashi
Tomohiro Yasui
Keisuke Tamari
Kazumasa Minami
Keisuke Otani
Fumiaki Isohashi
Yuji Seo
Ryosuke Kambe
Masahiko Koizumi
Kazuhiko Ogawa
author_facet Yutaka Takahashi
Tomohiro Yasui
Keisuke Tamari
Kazumasa Minami
Keisuke Otani
Fumiaki Isohashi
Yuji Seo
Ryosuke Kambe
Masahiko Koizumi
Kazuhiko Ogawa
author_sort Yutaka Takahashi
collection DOAJ
description Radiation therapy has been long utilized as localized cancer treatment. Recent studies have also demonstrated that it has a distant effect by the enhanced immunity, but it rarely occurs. The purpose of this study was to investigate whether X-ray irradiation combined with anti-PD-L1 and anti-CTLA-4 antibodies (P1C4) provides a higher probability of this distant effect as well as enhanced local antitumor efficacy for osteosarcoma. LM8 mouse osteosarcoma cells were inoculated into both legs of C3H mice assigned to one of four groups, namely no treatment (No Tx), P1C4, X-ray irradiation (RAD) to the leg of one side, and combination (COMB) groups. Survival and treatment-related immune molecular changes were analyzed. Administration of P1C4 produced a tumor growth delay on day 30 in 18% of the mice. In contrast, combination therapy produced the strongest tumor growth inhibition not only at the irradiated tumor but also at unirradiated tumor in 67% of the mice. Accordingly, lung metastasis in the COMB group was strongly reduced by 98%, with a significant survival benefit. Unirradiated tumor in mice in the COMB group significantly recruited CD8 + tumor-infiltrating lymphocytes with a moderate reduction of Treg, producing a significant increase in the CD8/Treg ratio. These results suggest that radiation enhances the efficacy of P1C4 treatment against distant metastasis as well as local control in osteosarcoma. Our data suggest that radiation therapy combined with dual checkpoint blockade may be a promising therapeutic option for osteosarcoma.
first_indexed 2024-12-20T09:50:53Z
format Article
id doaj.art-481dfd72f2354a8e823c81657e99675a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T09:50:53Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-481dfd72f2354a8e823c81657e99675a2022-12-21T19:44:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011212e018969710.1371/journal.pone.0189697Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.Yutaka TakahashiTomohiro YasuiKeisuke TamariKazumasa MinamiKeisuke OtaniFumiaki IsohashiYuji SeoRyosuke KambeMasahiko KoizumiKazuhiko OgawaRadiation therapy has been long utilized as localized cancer treatment. Recent studies have also demonstrated that it has a distant effect by the enhanced immunity, but it rarely occurs. The purpose of this study was to investigate whether X-ray irradiation combined with anti-PD-L1 and anti-CTLA-4 antibodies (P1C4) provides a higher probability of this distant effect as well as enhanced local antitumor efficacy for osteosarcoma. LM8 mouse osteosarcoma cells were inoculated into both legs of C3H mice assigned to one of four groups, namely no treatment (No Tx), P1C4, X-ray irradiation (RAD) to the leg of one side, and combination (COMB) groups. Survival and treatment-related immune molecular changes were analyzed. Administration of P1C4 produced a tumor growth delay on day 30 in 18% of the mice. In contrast, combination therapy produced the strongest tumor growth inhibition not only at the irradiated tumor but also at unirradiated tumor in 67% of the mice. Accordingly, lung metastasis in the COMB group was strongly reduced by 98%, with a significant survival benefit. Unirradiated tumor in mice in the COMB group significantly recruited CD8 + tumor-infiltrating lymphocytes with a moderate reduction of Treg, producing a significant increase in the CD8/Treg ratio. These results suggest that radiation enhances the efficacy of P1C4 treatment against distant metastasis as well as local control in osteosarcoma. Our data suggest that radiation therapy combined with dual checkpoint blockade may be a promising therapeutic option for osteosarcoma.http://europepmc.org/articles/PMC5734786?pdf=render
spellingShingle Yutaka Takahashi
Tomohiro Yasui
Keisuke Tamari
Kazumasa Minami
Keisuke Otani
Fumiaki Isohashi
Yuji Seo
Ryosuke Kambe
Masahiko Koizumi
Kazuhiko Ogawa
Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
PLoS ONE
title Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
title_full Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
title_fullStr Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
title_full_unstemmed Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
title_short Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
title_sort radiation enhanced the local and distant anti tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma
url http://europepmc.org/articles/PMC5734786?pdf=render
work_keys_str_mv AT yutakatakahashi radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma
AT tomohiroyasui radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma
AT keisuketamari radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma
AT kazumasaminami radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma
AT keisukeotani radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma
AT fumiakiisohashi radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma
AT yujiseo radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma
AT ryosukekambe radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma
AT masahikokoizumi radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma
AT kazuhikoogawa radiationenhancedthelocalanddistantantitumorefficacyindualimmunecheckpointblockadetherapyinosteosarcoma